1. Home
  2. LUNG vs BYND Comparison

LUNG vs BYND Comparison

Compare LUNG & BYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • BYND
  • Stock Information
  • Founded
  • LUNG 1995
  • BYND 2009
  • Country
  • LUNG United States
  • BYND United States
  • Employees
  • LUNG N/A
  • BYND N/A
  • Industry
  • LUNG Industrial Specialties
  • BYND Packaged Foods
  • Sector
  • LUNG Health Care
  • BYND Consumer Staples
  • Exchange
  • LUNG Nasdaq
  • BYND Nasdaq
  • Market Cap
  • LUNG 299.3M
  • BYND 265.3M
  • IPO Year
  • LUNG 2020
  • BYND 2019
  • Fundamental
  • Price
  • LUNG $7.35
  • BYND $3.26
  • Analyst Decision
  • LUNG Strong Buy
  • BYND Sell
  • Analyst Count
  • LUNG 7
  • BYND 6
  • Target Price
  • LUNG $12.64
  • BYND $4.92
  • AVG Volume (30 Days)
  • LUNG 284.5K
  • BYND 3.5M
  • Earning Date
  • LUNG 04-30-2025
  • BYND 05-07-2025
  • Dividend Yield
  • LUNG N/A
  • BYND N/A
  • EPS Growth
  • LUNG N/A
  • BYND N/A
  • EPS
  • LUNG N/A
  • BYND N/A
  • Revenue
  • LUNG $83,789,000.00
  • BYND $326,452,000.00
  • Revenue This Year
  • LUNG $17.96
  • BYND $3.65
  • Revenue Next Year
  • LUNG $18.35
  • BYND $1.84
  • P/E Ratio
  • LUNG N/A
  • BYND N/A
  • Revenue Growth
  • LUNG 22.01
  • BYND N/A
  • 52 Week Low
  • LUNG $5.46
  • BYND $2.86
  • 52 Week High
  • LUNG $10.01
  • BYND $10.31
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 46.66
  • BYND 41.55
  • Support Level
  • LUNG $7.65
  • BYND $3.42
  • Resistance Level
  • LUNG $7.97
  • BYND $3.70
  • Average True Range (ATR)
  • LUNG 0.44
  • BYND 0.22
  • MACD
  • LUNG -0.08
  • BYND 0.03
  • Stochastic Oscillator
  • LUNG 33.04
  • BYND 34.49

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

Share on Social Networks: